XtalPi
Teng Lin is currently the Senior Vice President of Business Development at XtalPi Inc. and a Senior Advisor at Integle China. Prior to this, Teng held the position of CEO at Zhongan Life Sciences Co., Ltd., a healthcare company focused on personalized healthcare services. With previous experiences in various roles at Schrödinger, Teng has a strong background in business development and scientific software development. Teng holds a Ph.D. in Chemistry from the University of Notre Dame and a BS in Polymer Chemistry and Computer Science from the University of Science and Technology of China.
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.